Subjects: S.2289 — 112th Congress (2011-2012)

  • Administrative law and regulatory procedures
  • Advisory bodies
  • Cancer
  • Child health
  • Congressional oversight
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Drug therapy
  • Food and Drug Administration (FDA)
  • Government information and archives
  • Health
  • Medical research